# Cooperative Research and Development Agreement (CRADA)

A Cooperative Research and Development Agreement (CRADA) is a legal agreement between a federal government agency or laboratory and one or more external partners, such as private companies, universities, nonprofits, or other government entities. Established under the Federal Technology Transfer Act of 1986 (15 U.S.C. 3710a), CRADAs are the most widely used technology transfer mechanism in the United States federal laboratory system. For technology professionals, understanding CRADAs is essential when evaluating pathways to collaborate with government research institutions, access specialized facilities, and bring federally developed innovations into commercial products and platforms.

## Purpose and Legal Foundation

CRADAs were created to bridge the gap between government-funded research and private-sector commercialization. The Stevenson-Wydler Technology Innovation Act of 1980 first mandated that federal laboratories actively participate in technology transfer. The Federal Technology Transfer Act of 1986 then introduced CRADAs as a formal mechanism to achieve this goal.

Under a CRADA, a federal laboratory contributes personnel, services, facilities, equipment, intellectual property, or other resources — but not direct funding — to a collaborative R&D effort. The external partner may contribute funds, personnel, services, equipment, or materials. This structure ensures that taxpayer-funded research reaches practical application without the government directly financing private ventures.

Key agencies that frequently use CRADAs include the Department of Defense (DoD), the Department of Energy (DOE), the National Institutes of Health (NIH), the National Institute of Standards and Technology (NIST), and NASA.

## How a CRADA Works

The lifecycle of a CRADA follows a structured process from initiation through completion:

- **Identification of mutual interest**: A federal lab researcher and an external partner identify a shared R&D objective that aligns with the lab's mission.
- **Proposal and negotiation**: The parties draft a CRADA proposal that defines the scope of work, contributions from each side, intellectual property terms, confidentiality provisions, and timelines.
- **Agency review and approval**: The federal laboratory's technology transfer office reviews the proposal for compliance with federal regulations, conflict-of-interest rules, and mission alignment.
- **Execution**: Once signed, the collaborative work begins. Each party contributes agreed-upon resources and personnel.
- **Reporting and closure**: Results are documented, intellectual property rights are allocated per the agreement, and the CRADA is formally closed upon completion.

A typical CRADA has a defined term, often ranging from one to five years, with options for renewal or extension depending on progress and mutual interest.

## Key Provisions and Terms

CRADAs contain several critical provisions that technology professionals should understand before entering negotiations:

| Provision | Description |
|---|---|
| **Scope of Work** | Defines the specific R&D activities, deliverables, and milestones for the collaboration. |
| **Contributions** | Details what each party provides — the government contributes facilities, equipment, and expertise; the partner contributes funding, materials, or personnel. |
| **Intellectual Property** | Specifies ownership of inventions, data rights, and background IP. The external partner typically receives an exclusive or non-exclusive license to inventions made under the CRADA. |
| **Confidentiality** | Protects proprietary information shared by the external partner from public disclosure, including FOIA exemptions for up to five years. |
| **Liability** | Establishes limitations on liability for each party and addresses indemnification. |
| **Publication Rights** | Allows government scientists to publish results, usually after a review period that lets the partner protect proprietary interests. |
| **Termination** | Defines conditions under which either party may end the agreement early and the obligations that survive termination. |

## Intellectual Property Rights

Intellectual property is often the most strategically important aspect of a CRADA for technology professionals. The IP framework under a CRADA is distinct from other federal contracting mechanisms:

- **Government-made inventions**: Inventions made solely by federal employees remain government property, but the CRADA partner can negotiate an exclusive or non-exclusive license.
- **Partner-made inventions**: Inventions made solely by the external partner's employees are owned by the partner.
- **Joint inventions**: Inventions made jointly are typically co-owned, with each party retaining certain rights. The partner can often negotiate an exclusive license to the government's share.
- **Data protection**: Proprietary data and trade secrets contributed by the partner are protected from public disclosure under 15 U.S.C. 3710a(c)(7), which exempts CRADA information from Freedom of Information Act (FOIA) requests for up to five years.
- **March-in rights**: The government retains the right to require licensing to third parties if the partner fails to commercialize the technology within a reasonable time or if public health and safety needs arise.

This IP structure gives private partners a strong incentive to invest in collaborative R&D while preserving the government's interest in ensuring public benefit.

## Benefits for Technology Professionals

CRADAs offer several strategic advantages that make them attractive to technology companies, startups, and research institutions:

- **Access to unique resources**: Federal laboratories house specialized equipment, testing facilities, and datasets that are often unavailable in the private sector — such as supercomputing clusters, wind tunnels, or biosafety-level-4 labs.
- **World-class expertise**: Government researchers include leading scientists and engineers in fields such as materials science, cybersecurity, energy systems, and biomedical engineering.
- **Reduced R&D costs**: By sharing resources and expertise, partners can reduce the time and expense required to develop and validate new technologies.
- **Preferential licensing**: CRADA partners receive the first option to negotiate exclusive licenses for inventions arising from the collaboration.
- **Technology validation**: Government testing and evaluation capabilities lend credibility to emerging technologies, which can accelerate market adoption and investor confidence.
- **FOIA protection**: Confidential business information shared under a CRADA is protected from public disclosure, reducing the risk of competitive exposure.

## CRADAs Compared to Other Federal Agreements

Technology professionals evaluating government collaboration options should understand how CRADAs compare to alternative mechanisms:

| Feature | CRADA | Federal Grant | Federal Contract | Other Transaction Authority (OTA) |
|---|---|---|---|---|
| **Government funding to partner** | No | Yes | Yes | Yes |
| **Partner funding to government** | Yes (allowed) | No | No | Yes (cost-sharing typical) |
| **IP rights for partner** | Strong (exclusive license option) | Limited (government use rights) | Limited (government purpose rights) | Negotiable |
| **FOIA protection** | Yes (up to 5 years) | No | Limited | Negotiable |
| **Flexibility in scope** | High | Moderate | Low (prescriptive SOW) | High |
| **Competition required** | No | Usually | Usually | Sometimes |
| **Best suited for** | Collaborative R&D | Basic research | Defined deliverables | Prototype development |

CRADAs stand out for their flexibility, strong IP protections for partners, and the ability to collaborate without the overhead of the federal procurement process.

## Common Use Cases in Technology

CRADAs have been used across a broad range of technology domains:

- **Cybersecurity**: Private companies partner with national laboratories to test defensive technologies, develop threat detection algorithms, and validate security architectures against advanced persistent threats.
- **Advanced materials**: Semiconductor and manufacturing firms collaborate with DOE labs to develop next-generation materials for chips, batteries, and structural components.
- **Artificial intelligence and machine learning**: Tech firms work with defense and intelligence laboratories to develop and validate AI models using government datasets and domain expertise.
- **Clean energy**: Energy companies partner with national labs to accelerate development of solar, wind, hydrogen, and nuclear technologies.
- **Biomedical technology**: Pharmaceutical and biotech companies collaborate with NIH to advance drug discovery, genomics research, and medical device development.
- **Standards and metrology**: Software and hardware companies work with NIST to develop measurement standards, testing protocols, and reference implementations for emerging technologies.

## Limitations and Considerations

While CRADAs offer significant advantages, technology professionals should be aware of potential challenges:

- **No direct government funding**: The government cannot transfer funds to the partner under a CRADA. Partners must self-fund their contributions or seek complementary funding sources.
- **Negotiation timelines**: Federal review and approval processes can take several months, which may not align with fast-moving commercial timelines.
- **Mission alignment requirement**: The proposed research must align with the federal laboratory's mission. Projects driven purely by commercial interest without a public benefit component may not be approved.
- **Publication and disclosure**: Government researchers retain the right to publish results, which can conflict with a partner's desire to keep innovations proprietary during early development.
- **March-in rights**: The government's retained right to require licensing can introduce uncertainty, though these rights are rarely exercised in practice.
- **Organizational complexity**: Working within federal bureaucracy requires patience and familiarity with government processes, timelines, and decision-making structures.

## How to Initiate a CRADA

Technology professionals interested in pursuing a CRADA should follow these steps:

- **Identify a target laboratory**: Research which federal labs conduct work relevant to your technology area. The Federal Laboratory Consortium (FLC) maintains a searchable directory.
- **Engage the technology transfer office**: Contact the lab's Office of Research and Technology Applications (ORTA) to discuss potential collaboration.
- **Define the scope collaboratively**: Work with laboratory scientists to develop a mutually beneficial scope of work.
- **Prepare your contribution plan**: Determine what resources — funding, personnel, equipment, or materials — you can commit.
- **Negotiate terms**: Work with the ORTA and legal counsel to negotiate IP, confidentiality, and other key terms.
- **Execute and manage**: Once signed, actively manage the collaboration with regular communication, milestone tracking, and joint reviews.

## Related

Technology professionals exploring CRADAs should also study technology transfer and its mechanisms, joint development agreements, joint venture agreements, licensing agreements, intellectual property management, government partnership models, public-private partnerships, research and development strategy, the Federal Laboratory Consortium, and Other Transaction Authority (OTA) agreements. Understanding these related concepts provides a broader view of how government-industry collaboration can drive innovation and commercialization.

## Summary

A Cooperative Research and Development Agreement (CRADA) is the primary legal mechanism through which U.S. federal laboratories collaborate with private companies, universities, and other external organizations on research and development. CRADAs provide technology professionals with access to world-class government facilities, expertise, and datasets without requiring a traditional procurement process, while offering strong intellectual property protections and confidentiality safeguards. Though the government does not provide direct funding under a CRADA, the combination of resource sharing, preferential licensing rights, and FOIA-protected data exchange makes CRADAs a powerful tool for accelerating technology development and reducing time to market. Success with CRADAs requires careful negotiation, mission alignment with the host laboratory, and active management of the collaborative relationship.

## References

- Federal Technology Transfer Act of 1986, 15 U.S.C. 3710a. https://www.law.cornell.edu/uscode/text/15/3710a
- Stevenson-Wydler Technology Innovation Act of 1980, 15 U.S.C. 3701 et seq. https://www.law.cornell.edu/uscode/text/15/3701
- Federal Laboratory Consortium for Technology Transfer (FLC). https://www.federallabs.org/
- National Institute of Standards and Technology (NIST), Technology Partnerships Office. https://www.nist.gov/tpo
- Department of Energy, Office of Technology Transitions. https://www.energy.gov/technologytransitions
- National Institutes of Health, Office of Technology Transfer. https://www.ott.nih.gov/
